학술논문

Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer
Document Type
Article
Source
In: Gynecologic Oncology. (Gynecologic Oncology, April 2024, 183:25-32)
Subject
Language
English
ISSN
10956859
00908258